The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device

European Journal of Cardio-thoracic Surgery

Volumn 23, Issue 5, 2003, Pages 748-755

  Siegenthaler, M P ^a   Martin, J ^a   Pernice, K ^a   Doenst, T ^a   Sorg, S ^a   Trummer, G ^a   Friesewinkel, O ^a   Beyersdorf, F ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Heart failure; Infection; Jarvik 2000; Left ventricular assist device; TCI Heartmate

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFOTIAM; CEFTAZIDIME; CEFUROXIME; CILASTATIN; CIPROFLOXACIN; FLUCONAZOLE; IMIPENEM; INOTROPIC AGENT; METRONIDAZOLE; PIPERACILLIN; SULTAMICILLIN; TAZOBACTAM; VANCOMYCIN;

ADULT; BLEEDING; BLOOD FLOW; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DEVICE; DISEASE CONTROL; DRIVE; FEMALE; GRAFT INFECTION; HEART; HEART INDEX; HEART LEFT VENTRICLE; HEMATOMA; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; POWER SUPPLY; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SEPTICEMIA; SUPPORT GROUP; WOUND CARE;

ANTI-BACTERIAL AGENTS; DRUG COSTS; FEMALE; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT READMISSION; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0037660184     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(03)00073-3     Document Type: Conference Paper

References (15)

1. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL, Meier P, the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435-1443.
2. Argenziano M., Catanese K.A., Moazami N., Gardocki M.T., Weinberg A.D., Clavenna M.W., Rose E.A., Scully B.E., Levin H.R., Oz M.C. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant. 16:1997;822-831.
3. Westaby S., Banning A.P., Jarvik R., Frazier O.H., Pigott D.W., Jin X.Y., Catarino P.A., Saito S., Robson D., Freeland A., Myers T.J., Poole-Wilson P.A. First permanent implant of the Jarvik Heart. Lancet. 356:2000;900-903.
4. Parkin J.L. Percutaneous pedestal in cochlear implantation. Ann Otol Rhinol Laryngol. 99:1990;796-800.
5. Westaby S., Frazier O.H., Pigott D.W., Saito S., Jarvik R.K. Implant technique for the Jarvik 2000 Heart. Ann Thorac Surg. 73:2002;1337-1340.
6. Siegenthaler M.P., Martin J., Frazier O.H., Beyersdorf F. Implantation of the permanent Jarvik-2000 left-ventricular-assist-device: surgical technique. Eur J Cardiothorac Surg. 21:2002;546-548.
7. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections. Am J Infect Control. 16:1988;128-140.
8. Horan T.C., Gaynes R.P., Martone W.J., Jarvis W.R., Emori T.G. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control. 20:1992;271-274.
9. Altman D.G. Practical statistics for medical research. 1991;Chapman & Hall, London.
10. Malani P.N., Dyke D.B., Pagani F.D., Chenoweth C.E. Nosocomial infections in left ventricular assist device recipients. Clin Infect Dis. 34:2002;1295-1300.
11. Herrmann M., Weyand M., Greshake B., von Eiff C., Proctor R.A., Scheld H.H., Peters G. Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. Circulation. 95:1997;814-817.
12. Sinha P., Chen J.M., Flannery M., Scully B.E., Oz M.C., Edwards N.M. Infections during left ventricular assist device support do not affect posttransplant outcomes. Circulation. 102:2000;7.
13. MacCarthy P.A., Schmitt S.K., Vargo R.L., Gordon S., Keys T.F., Hobbs R.E. Implantable LVAD infections: implications for permanent use of the device. Ann Thorac Surg. 61:1996;359-365.
14. Oz M.C., Goldstein D.J., Pepino P., Weinberg A.D., Thompson S.M., Catanese K.A., Vargo R.L., McCarthy P.M., Rose E.A., Levin H.R. Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation. 92:1995;II169-II173.
15. Aaronson K.D., Schwartz J.S., Chen T.M., Wong K.L., Goin J.E., Mancini D.M. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation [see comments]. Circulation. 95:1997;2660-2667.